...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019

Thanks BDZ,

I don't understand why they use Alzheimers in this statement as we are ONLY testing VD and not Alzheimers, ..?

  • Epigenetics, the BET-system, Alzheimer’s Disease and Vascular Cognitive Impairment; The BETonMACE study and effects of apabetalone 100 mg b.i.d. two years treatment on cognition in diabetes patients with established cardiovascular disease: Dr. Jeffrey Cummings, Cleveland Clinic Lou Ruvo Center for Brain Health, USA
Share
New Message
Please login to post a reply